FOX04-DRI

FOXO4-DRI also known as (PROXOFIM) is a synthetic analog of FOXO4 engineered as a D-retro inverso peptide to disrupt the interaction between FOXO4 and p53. Research suggests that by blocking this interaction, FOXO4-DRI promotes apoptosis specifically in senescent cells while sparing healthy cells. This senolytic effect has made FOXO4-DRI a peptide of high interest in studies on aging, tissue regeneration, and age-related decline.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption